Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9053991 | 0.80 | TSHR (0.50) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL234098 | 0.79 | TDP1 (0.40) | ALDH1A1SMN1; SMN2TDP1TSHRTP53 | |
| SCHEMBL27924079 | 0.78 | SMN1; SMN2 (0.40) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL232506 | 0.78 | ESR1 (0.42) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL7574561 | 0.77 | TSHR (0.58) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL8677759 | 0.76 | BCHE (0.38) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL27994199 | 0.75 | TDP1 (0.49) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL3681261 | 0.73 | TSHR (0.44) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL4645429 | 0.73 | TDP1 (0.33) | ALDH1A1SMN1; SMN2TDP1TSHRTP53 | |
| SCHEMBL4782428 | 0.73 | ESR1 (0.35) | ALDH1A1TDP1TSHRCYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116057043-B | Urea derivatives and their use as curing agents and curing accelerators for resin systems | 赫克塞尔合成有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11939421-B2 | Or relating to curing agents | HEXCEL COMPOSITES LIMITED (GB) | 2024-03-26 | — | — | US | disclosed |
| US-11879052-B2 | Curatives | HEXCEL COMPOSITES LIMITED (GB) | 2024-01-23 | — | — | US | disclosed |
| US-11702516-B2 | Curative composition and a resin composition containing the curative composition | HEXCEL COMPOSITES LIMITED (GB) | 2023-07-18 | — | — | US | disclosed |
| EP-4196462-A1 | UREA DERIVATIVES AND THEIR USE AS CURATIVES AND CURATIVE ACCELERATORS FOR RESIN SYSTEMS | Hexcel Composites Limited (GB) | 2023-06-21 | — | — | EP | disclosed |
| US-20230167272-A1 | IMPROVEMENTS IN OR RELATING TO CURATIVES | HEXCEL COMPOSITES LIMITED (GB) | 2023-06-01 | — | — | US | disclosed |
| CN-116057043-A | Urea derivatives and their use as curing agents and curing accelerators for resin systems | 赫克塞尔合成有限公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-4017904-A1 | IMPROVED THERMOCURABLE MOULDING PROCESS | Hexcel Composites Limited (GB) | 2022-06-29 | — | — | EP | disclosed |
| WO-2022034201-A1 | UREA DERIVATIVES AND THEIR USE AS CURATIVES AND CURATIVE ACCELERATORS FOR RESIN SYSTEMS | HEXCEL COMPOSITES LIMITED (GB) | 2022-02-17 | — | — | WO | disclosed |
| EP-3950849-A1 | LATENT HEAT STORAGE MATERIAL | Kaneka Corporation (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-20130158231-A1 | LIQUID CURABLE EPOXY RESIN COMPOSITION AND ADHESIVE AGENT CONTAINING SAME | NIPPON SODA CO., LTD. (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20120088920-A1 | CLATHRATE COMPOUND, CURING CATALYST, COMPOSITION FOR FORMING CURED RESIN, AND CURED RESIN | NIPPON SODA CO., LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| EP-2410001-A1 | INCLUSION COMPLEX, CURING AGENT, CURE ACCELERATOR, EPOXY RESIN COMPOSITION, AND EPOXY RESIN COMPOSITION FOR ENCAPSULATION OF SEMICONDUCTOR | Nippon Soda Co., Ltd. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20120004349-A1 | Epoxy resin composition, curing agent, and curing accelerator | NIPPON SODA CO., LTD. | 2012-01-05 | — | — | US | disclosed |
| US-20120004377-A1 | CLATHRATE, CURING AGENT, CURE ACCELERATOR, EPOXY RESIN COMPOSITION, AND EPOXY RESIN COMPOSITION FOR ENCAPSULATION OF SEMICONDUCTOR | NIPPON SODA CO., LTD. | 2012-01-05 | — | — | US | disclosed |
| US-20100022744-A1 | CLATHRATE COMPOUND, CURING CATALYST, COMPOSITION FOR FORMING CURED RESIN, AND CURED RESIN | NIPPON SODA CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2103600-A1 | CLATHRATE COMPOUND, CURING CATALYST, COMPOSITION FOR FORMING CURED RESIN, AND CURED RESIN | Nippon Soda Co., Ltd. (JP) | 2009-09-23 | — | — | EP | disclosed |
| EP-0761722-B1 | ORGANOPOLYSILOXANE DERIVATIVE | NAGASE CIBA LTD (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-5844053-A | Organo-polysiloxane derivartives | NAGASE-CIBA, LTD. (JP) | 1998-12-01 | — | — | US | disclosed |
| EP-0761722-A1 | ORGANOPOLYSILOXANE DERIVATIVE | Nagase-Ciba Ltd. (JP) | 1997-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004377-A1 | CLATHRATE, CURING AGENT, CURE ACCELERATOR, EPOXY RESIN COMPOSITION, AND EPOXY RESIN COMPOSITION FOR ENCAPSULATION OF SEMICONDUCTOR | SEM1, RCC1, BMI1 | ALDH1A1 619/4885SMN1; SMN2 918/4885TDP1 889/4885 |
| US-20100022744-A1 | CLATHRATE COMPOUND, CURING CATALYST, COMPOSITION FOR FORMING CURED RESIN, AND CURED RESIN | HEATR1, NISCH, HEATR6 | ALDH1A1 1369/4885SMN1; SMN2 2840/4885TDP1 3822/4885 |
| US-20120004349-A1 | Epoxy resin composition, curing agent, and curing accelerator | DCTN1, ARCN1, UNC119 | ALDH1A1 338/4885SMN1; SMN2 2196/4885TDP1 1130/4885 |
| US-11939421-B2 | Or relating to curing agents | FABP4, RARA, ADIPOR1 | ALDH1A1 131/4885SMN1; SMN2 2881/4885TDP1 1408/4885 |
| US-20120088920-A1 | CLATHRATE COMPOUND, CURING CATALYST, COMPOSITION FOR FORMING CURED RESIN, AND CURED RESIN | HEATR1, CBR1, ASIC1 | ALDH1A1 1412/4885SMN1; SMN2 3025/4885TDP1 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.